The Association of Prior Intensive Lifestyle Intervention and Diabetes Support and Education With Frailty Prevalence at Long-Term Follow-Up in the Action for Health in Diabetes Extension Study
- PMID: 34637524
- PMCID: PMC9536442
- DOI: 10.1093/gerona/glab312
The Association of Prior Intensive Lifestyle Intervention and Diabetes Support and Education With Frailty Prevalence at Long-Term Follow-Up in the Action for Health in Diabetes Extension Study
Abstract
Background: Frailty is common in older adults with obesity and diabetes. We compared prevalence of the frailty phenotype between intervention groups in long-term follow-up of Look Action for Health in Diabetes Study (AHEAD), a randomized trial comparing a multidomain intensive lifestyle intervention (ILI) that promoted weight loss and physical activity with a diabetes support and education (DSE) control group in adults with type 2 diabetes and overweight or obesity.
Method: Participants included 2 979 individuals randomized to ILI or DSE in 2001-2004 who completed frailty assessment in Look AHEAD-Extension Wave 1 (2016-2018) at an average age of 72.1 ± 6.2 years. Frailty was assessed using a modified frailty phenotype definition (excluding weight loss) defined as the presence of 3 or more of the following frailty characteristics: weakness, slow gait speed, low physical activity, and exhaustion. Frailty odds by intervention assignment (DSE vs ILI) were estimated using multivariable logistic regression, adjusting for sex, clinic site, and time since randomization.
Results: At median follow-up of 14.0 years (interquartile range: 13.8-14.1), frailty prevalence was 10.9% in ILI compared with 11.6% in DSE (odds ratio for frailty in ILI vs DSE = 0.94, 95% confidence interval: 0.75-1.18, p = .60). Frailty was more prevalent in participants who were older, female, non-White, of lower socioeconomic status, and at baseline had a higher body mass index and waist circumference, longer duration of diabetes, history of cardiovascular disease, and metabolic syndrome.
Conclusions: Prior randomization to ILI compared with DSE was not associated with a lower prevalence of frailty after a median follow-up of 14.0 years in adults with diabetes and overweight or obesity.
Keywords: Clinical trials; Diabetes; Frailty; Lifestyle intervention.
Published by Oxford University Press on behalf of The Gerontological Society of America 2021.
Similar articles
-
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.Lancet Diabetes Endocrinol. 2014 Oct;2(10):801-9. doi: 10.1016/S2213-8587(14)70156-1. Epub 2014 Aug 10. Lancet Diabetes Endocrinol. 2014. PMID: 25127483 Free PMC article. Clinical Trial.
-
Association of the Intensive Lifestyle Intervention With Total Knee Replacement in the Look AHEAD (Action for Health in Diabetes) Clinical Trial.J Arthroplasty. 2020 Jun;35(6):1576-1582. doi: 10.1016/j.arth.2020.01.057. Epub 2020 Feb 19. J Arthroplasty. 2020. PMID: 32085906 Free PMC article. Clinical Trial.
-
Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study.Int J Obes (Lond). 2009 Mar;33(3):305-16. doi: 10.1038/ijo.2008.280. Epub 2009 Jan 20. Int J Obes (Lond). 2009. PMID: 19153582 Free PMC article. Clinical Trial.
-
The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):69-75. doi: 10.1016/j.pcad.2015.04.002. Epub 2015 Apr 30. Prog Cardiovasc Dis. 2015. PMID: 25936906 Free PMC article. Review.
-
Does Lifestyle Intervention Improve Health of Adults with Overweight/Obesity and Type 2 Diabetes? Findings from the Look AHEAD Randomized Trial.Obesity (Silver Spring). 2021 Aug;29(8):1246-1258. doi: 10.1002/oby.23158. Epub 2021 May 14. Obesity (Silver Spring). 2021. PMID: 33988896 Review.
Cited by
-
Long-term Impact of a 10-Year Intensive Lifestyle Intervention on a Deficit Accumulation Frailty Index: Action for Health in Diabetes Trial.J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2119-2126. doi: 10.1093/gerona/glad088. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36946420 Free PMC article. Clinical Trial.
-
Nutritional Interventions in Older Persons with Type 2 Diabetes and Frailty: A Scoping Systematic Review.J Cardiovasc Dev Dis. 2024 Sep 18;11(9):289. doi: 10.3390/jcdd11090289. J Cardiovasc Dev Dis. 2024. PMID: 39330347 Free PMC article.
-
The intersection of frailty and metabolism.Cell Metab. 2024 May 7;36(5):893-911. doi: 10.1016/j.cmet.2024.03.012. Epub 2024 Apr 12. Cell Metab. 2024. PMID: 38614092 Free PMC article. Review.
-
Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.JAMA Netw Open. 2022 Sep 1;5(9):e2231206. doi: 10.1001/jamanetworkopen.2022.31206. JAMA Netw Open. 2022. PMID: 36098968 Free PMC article. Clinical Trial.
-
Short- and Long-Term Effect of Multidomain Lifestyle Intervention on Frailty: Post Hoc Analysis of an RCT.J Am Geriatr Soc. 2025 Aug;73(8):2457-2465. doi: 10.1111/jgs.19552. Epub 2025 May 30. J Am Geriatr Soc. 2025. PMID: 40444985 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
- P30 DK48520/Clinical Nutrition Research Unit
- U01 DK057154/DK/NIDDK NIH HHS/United States
- VA/VA/United States
- U01 DK057182/DK/NIDDK NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- U01 DK057078/DK/NIDDK NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- M01RR0021140/University of Tennessee
- M01RR02719/Johns Hopkins Medical Institutions Bayview General Clinical Research Center
- CC/CDC HHS/United States
- U01 DK057151/DK/NIDDK NIH HHS/United States
- M01RR01066/Massachusetts Institute of Technology General Clinical Research Center
- HL/NHLBI NIH HHS/United States
- RR025758-04/Harvard Clinical and Translational Science Center
- P30 DK048520/DK/NIDDK NIH HHS/United States
- R01 AG058571/AG/NIA NIH HHS/United States
- DK57136/DK/NIDDK NIH HHS/United States
- AG058571/AG/NIA NIH HHS/United States
- NR/NINR NIH HHS/United States
- M01 RR002719/RR/NCRR NIH HHS/United States
- M01 RR000056/RR/NCRR NIH HHS/United States
- U01 DK057219/DK/NIDDK NIH HHS/United States
- National Center on Minority Health and Health Disparities
- U01 DK056992/DK/NIDDK NIH HHS/United States
- U01 DK057131/DK/NIDDK NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- M01RR00051/University of Colorado Health Sciences Center General Clinical Research Center
- NH/NIH HHS/United States
- M01RR000056/University of Pittsburgh General Clinical Research Center
LinkOut - more resources
Full Text Sources
Medical